MMA Asset Management
GOSS icon

MMA Asset Management’s Gossamer Bio GOSS Stock Holding History

MMA Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-125
Closed -$1.65K – 193
2026
Q2 		$1.65K Hold
125
– – ﹤0.01% 181
2026
Q1 		$3.28K Hold
125
– – ﹤0.01% 179
2025
Q4 		$31K Buy
+125
New +$28.5K 0.01% 182

Other funds holding GOSS

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $38.9M AUM 12.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
MB Generational Wealth
MB Generational Wealth Spokane, Washington $196M AUM 14.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

MMA Asset Management's GOSS Position: Q3 2026 in Review

MMA Asset Management sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 125 shares — an estimated $1.65K sold.

MMA Asset Management first reported a position in GOSS in Q4 2025 and held it in 3 quarters. The position peaked at $31K in Q4 2025. 37 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • MMA Asset Management reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • MMA Asset Management sold 125 Gossamer Bio shares in Q3 2026, an estimated $1.65K.
  • MMA Asset Management first reported a position in Gossamer Bio in Q4 2025 and held it in 3 quarters.
  • MMA Asset Management's Gossamer Bio position peaked at $31K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on MMA Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.